Literature DB >> 27004543

Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.

Tomasz Zdrojewski1, Bogdan Solnica, Barbara Cybulska, Piotr Bandosz, Marcin Rutkowski, Jakub Stokwiszewski, Zbigniew Gaciong, Maciej Banach, Bogdan Wojtyniak, Michael Pencina, Bogdan Wyrzykowski.   

Abstract

BACKGROUND: Poland represents a country of high cardiovascular (CV) risk. The association between lipid abnormalities and increased CV risk is well established. Therefore, it is important to monitor the prevalence and control of dyslipidaemia. AIM: To evaluate serum lipids concentrations as well as the prevalence, awareness, and control of lipid abnormalities in a representative sample of adults in Poland.
METHODS: In 2011, in a national cross-sectional survey blood samples were collected from 1168 males and 1245 females, aged 18-79 years, for measurement of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in blood serum. Low density lipoprotein cholesterol (LDL-C) was calculated using Friedewald's formula.
RESULTS: Mean serum TC concentration was 197.1 mg/dL (95% CI 193.8-200.4) in males (M) and 198.6 mg/dL (95% CI 195.7-201.5) in females (F). Levels of LDL-C were 123.6 mg/dL (120.9-126.2) and 123.7 mg/dL (121.4-126.1), HDL-C - 45.8 mg/dL (44.7-47.0) and 54.1 mg/dL (53.1-55.1), TG - 140.9 mg/dL (133.0-148.8) and 104.0 mg/dL (99.8-108.2) for males and females, respectively. TC ≥ 190 mg/dL was found in 54.3% subjects (M 54.3%; F 54.4%). After adding patients on lipid-lowering treatment, hypercholesterolaemia was present in 61.1% of adults (M 60.8%; F 61.3%). LDL-C ≥ 115 mg/dL was detected in 57.8% of all subjects (M 58.3%; F 57.3%), while HDL-C < 40 mg/dL in 35.2% of males and < 45 mg/dL in 22% of females TG ≥ 150 mg/dL was found in 21.1% of subjects (M 28.4%; F 14.0%). The highest prevalence of elevated TC and LDL-C levels was present in the age group of 40-59-year-olds. Of those with hypercholesterolaemia 58.7% (M 61.5%, F 56.0%) were not aware of the condition; 22.0% (M 21.0%, F 24.5%) were aware but were not being treated; 8.1% (M 7.7%, F 8.5%) were treated but with TC ≥ 190 mg/dL; and only 10.9% (M 10.7%, F 11.0%) were being treated with TC < 190 mg/dL.
CONCLUSIONS: The prevalence of dyslipidaemia in Poland continues to be high--over 60% of adults have hypercholesterolaemia, and control remains poor. The results of the NATPOL 2011 survey call for urgent preventive measures.

Entities:  

Keywords:  and control of dyslipidaemia; awareness; cross sectional; lipids; nationally representative survey; prevalence

Mesh:

Substances:

Year:  2016        PMID: 27004543     DOI: 10.5603/KP.2016.0029

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  18 in total

1.  PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

Authors:  Maciej Banach; Piotr Jankowski; Jacek Jóźwiak; Barbara Cybulska; Adam Windak; Tomasz Guzik; Artur Mamcarz; Marlena Broncel; Tomasz Tomasik; Jacek Rysz; Agnieszka Jankowska-Zduńczyk; Piotr Hoffman; Agnieszka Mastalerz-Migas
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

2.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

3.  Assessing the effect of socioeconomic factors on prevalence of dyslipidemia among iranian adult population; district level analysis from 2016 STEPS national study using small area estimation.

Authors:  Hamidreza Soleimani; Erfan Ghasemi; Sahar Saeedi Moghaddam; Sina Azadnajafabad; Negar Rezaei; Masoud Masinaei; Shohreh Naderimagham; Nazila Rezaei; Mohammad-Reza Malekpour; Mohammad Keykhaei; Fateme Gorgani; Ameneh Kazemi; Saba Tahmasebi; Rashed Makhdoom; Farshad Farzadfar
Journal:  J Diabetes Metab Disord       Date:  2022-04-05

4.  Cardiovascular risk and metabolic profile of Polish citizens from Lower Silesia. First signs of metabolic crisis?

Authors:  Lukasz Kozera; Wiktor Kuliczkowski; Elzbieta Gocek
Journal:  Arch Med Sci       Date:  2020-10-14       Impact factor: 3.707

5.  Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction.

Authors:  Aleksander Siniarski; Rafal Grzybczak; Pawel Rostoff; Jaroslaw Zalewski; Urszula Czubek; Jadwiga Nessler; Grzegorz Gajos
Journal:  Anatol J Cardiol       Date:  2018-06       Impact factor: 1.596

6.  The Gene-Diet Associations in Postmenopausal Women with Newly Diagnosed Dyslipidemia.

Authors:  B Grygiel-Górniak; E Kaczmarek; M Mosor; J Przysławski; J Nowak
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

7.  Relation between cognitive impairment and treatment adherence in elderly hypertensive patients.

Authors:  Anna Chudiak; Izabella Uchmanowicz; Grzegorz Mazur
Journal:  Clin Interv Aging       Date:  2018-08-06       Impact factor: 4.458

8.  Impact of oscillatory-cycloid vibration interventions on body composition, waist and hip circumference, and blood lipid profile in women aged over 65 years with hypercholesterolaemia.

Authors:  Anna M Piotrowska; Monika Bigosińska; Halina Potok; Urszula Cisoń-Apanasewicz; Olga Czerwińska-Ledwig; Łukasz M Tota; Roxana Zuziak; Tomasz Pałka; Wanda Pilch
Journal:  Prz Menopauzalny       Date:  2018-12-31

9.  How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?

Authors:  Bartosz Uchmanowicz; Anna Chudiak; Izabella Uchmanowicz; Grzegorz Mazur
Journal:  Int J Hypertens       Date:  2019-01-06       Impact factor: 2.420

10.  Uric acid and obesity-related phenotypes in postmenopausal women.

Authors:  B Grygiel-Górniak; M Mosor; J Marcinkowska; J Przysławski; J Nowak
Journal:  Mol Cell Biochem       Date:  2017-10-26       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.